Clinical Study Using A New Phacoemulsification System With Surgical Intraocular Pressure Control
Clinical Study Using A New Phacoemulsification System With Surgical Intraocular Pressure Control
PURPOSE: To compare cumulative dissipated energy (CDE), aspiration fluid used, and aspiration
time during phacoemulsification cataract extraction using 2 surgical configurations.
SETTING: Two clinical sites in the United States and 1 in Spain.
DESIGN: Prospective randomized clinical case series.
METHODS: For each patient, the first eye having surgery was randomized to the active-fluidics
configuration (Centurion Vision System with Active Fluidics, 0.9 mm 45-degree Intrepid
Balanced tip, and 0.9 mm Intrepid Ultra infusion sleeve) or the gravity-fluidics configuration
(Infiniti Vision System with gravity fluidics, 0.9 mm 45-degree Mini-Flared Kelman tip, and
0.9 mm Ultra infusion sleeve). Second-eye surgery was completed within 14 days after first-eye
surgery using the alternate configuration. The CDE, aspiration fluid used, and aspiration time
were compared between configurations, and adverse events were summarized.
RESULTS: Patient demographics and cataract characteristics were similar between configurations
(100 per group). The CDE was significantly lower with the active-fluidics configuration than with the
gravity-fluidics configuration (mean G standard error, 4.32 G 0.28 percent-seconds) (P < .001).
The active-fluidics configuration used significantly less aspiration fluid than the gravity-fluidics
configuration (mean 46.56 G 1.39 mL versus 52.68 G 1.40 mL) (P < .001) and required
significantly shorter aspiration time (mean 151.9 G 4.1 seconds versus 167.6 G 4.1 seconds)
(P < .001). No serious ocular adverse events related to the study devices or device deficiencies
were observed.
CONCLUSION: Significantly less CDE, aspiration fluid used, and aspiration time were observed with
the active-fluidics configuration than with the gravity-fluidics configuration, showing improved
surgical efficiency.
Financial Disclosures: Drs. Solomon and Cionni are consultants to Alcon Research, Ltd., and
received compensation for conduct of the study. Dr. Lorente received compensation for clinical
work in the study. Mr. Fanney is an employee of Alcon Research, Ltd.
J Cataract Refract Surg 2016; 42:542549 Q 2016 ASCRS and ESCRS
An estimated 20 million cataract surgical procedures intraocular pressure (IOP), which can vary during sur-
are performed annually, with phacoemulsification gery because of 2 primary factors. First, changes in
being the surgical method of choice.1,2 Advances in aspiration and infusion flow rates can cause fluctua-
phacoemulsifier/aspirator (phaco) systems, fluidics, tions in IOP. In addition, postocclusion break
ultrasound (US) tips, and US sleeves continue to be response, which occurs when fluid floods the aspira-
made with the goal of improving surgical efficiency tion port after a phacoemulsification tip is unoccluded,
and patient outcomes after cataract surgery. can create a transient pressure drop. The transient
Maintaining anterior chamber stability is a key decrease in surgical IOP during postocclusion surge
factor in facilitation of successful cataract surgery. events increases the risk for surgical complications
However, anterior chamber stability is affected by such as posterior capsule rupture.3,4 One of the newest
phaco systems available is the Centurion Vision Sys- the phacoemulsification tip was in the eye) and was
tem (Alcon Laboratories, Inc.). This system can use associated with less postoperative corneal edema.10
standard gravity fluidics with an irrigation bottle or The new Centurion Vision System system improves
an Active Fluidics system with a compressible irriga- on the fluidics of the Infiniti Vision System, and
tion bag. When using the irrigation bag, the active together with the newly offered Intrepid Balanced
control system applies variable infusion pressure to US tip, might lead to better surgical efficiency during
compensate for variations in fluid flow rate and pro- cataract procedures. The goal of this study was to
vide for better surgical IOP stability by reducing IOP compare the intraoperative surgical efficiency metrics
fluctuations during surgery.A,B The postocclusion (cumulative dissipated energy [CDE], aspiration time,
response is also improved, as was recently shown in and aspiration fluid used) between the Centurion
a laboratory study comparing postocclusion surge be- system configured with the Intrepid Balanced tip
tween 3 currently used systems.5 The tested systems compared with the Infiniti system configured with
included the Infiniti Vision System (Alcon Labora- the standard Mini-Flared Kelman tip during routine
tories, Inc.) and the Centurion. The Centurion consis- phacoemulsification extraction of cataracts with lens
tently achieved the lowest postocclusion surge levels, opacities of nuclear (N) N0 to NIII, as classified by
suggesting the potential for better IOP stability during the Lens Opacities Classification System II (LOCS II).11
surgery.
The Infiniti was selected as a comparator in this PATIENTS AND METHODS
study because it is a commonly used phaco system.
Study Design
In a survey-based study of surgeons in Canada and
the United States, 59% reported that Infiniti was their This was a prospective randomized multicenter patient-
and clinical technician-masked 2-arm paired-eye compari-
first-choice system.6 son study performed at 2 sites in the United States and
The torsional US feature of the Infiniti system was 1 site in Spain between July 2013 and February 2014 (U.S. Na-
introduced in addition to traditional (ie, longitudinal) tional Institutes of Health Clinical Trials identifier
US; the torsional operating modality of the Infiniti NCT01848288).C Enrolled patients were randomized to 1 of
was shown to decrease heat production,7,8 surgical 2 surgical configurations for first-eye surgery in a ratio of
1:1 for each surgeon. Surgeons graded cataracts before
time, and aspiration fluid volume compared with tradi- randomization in an unmasked fashion by comparison
tional US.9,10 Compared with a phaco system operated with standardized LOCS II photographs.11 The eye with
in longitudinal mode, phacoemulsification with the In- the worse cataract was selected as the first operative eye. If
finiti system in torsional mode was completed with less the cataract grade was equal between eyes, the right eye
mean phacoemulsification time (ie, the duration that was selected. Second-eye surgery was performed within
14 days after first-eye surgery using the alternate configura-
tion. The active-fluidics configuration comprised the Centu-
rion Vision System with Active Fluidics, the 0.9 mm
45-degree aspiration bypass system Intrepid Balanced
Submitted: August 11, 2015. tip, and the 0.9 mm Intrepid Ultra infusion sleeve (Figure 1,
Final revision submitted: January 15, 2016. A). The gravity-fluidics configuration used the Infiniti Vision
Accepted: January 20, 2016. System with gravity fluidics, the 0.9 mm 45-degree aspira-
tion bypass system Mini-Flared Kelman tip, and the
From the Carolina Eyecare Physicians (Solomon), Charleston, 0.9 mm Ultra infusion sleeve (Figure 1, B). The Ozil hand-
South Carolina, Alcon Research, Ltd. (Fanney), Irvine, California, piece (Alcon Laboratories, Inc.) was used with both surgical
and the Eye Institute of Utah (Cionni), Salt Lake City, Utah, USA; configurations for all surgeries. Because all participating sur-
Complejo Hospitalario Universitario Orense (Lorente), Orense, geons had ample experience with the Infiniti system,
Spain. whereas the Centurion system was new, all investigators
were required to have used the Centurion 100 or more times
Supported by Alcon Laboratories, Inc., Fort Worth, Texas, USA. to gain sufficient experience before study initiation.
Bickol Mukesh, PhD, assisted with the statistical analyses. Medical
writing assistance was provided by Heather D. Starkey, PhD, Com- Patients
plete Healthcare Communications, Chadds Ford, Pennsylvania, Eligible patients provided written informed consent, were
USA, and was funded by Alcon Laboratories, Inc. 55 years or older with a diagnosis of cataracts with lens opac-
ities of N0 to NIII classified using the LOCS II,11 and had
Presented in part at the ASCRS Symposium on Cataract, IOL and planned bilateral phacoemulsification cataract extraction
Refractive Surgery, Boston, Massachusetts, USA, April 2014, and with implantation of Acrysof intraocular lenses (IOLs) (Al-
at the XXXII Congress of the European Society of Cataract and con Laboratories, Inc.). Patients must have been willing to
Refractive Surgeons, London, United Kingdom, September 2014. have second-eye surgery within 14 days of first-eye surgery.
Key exclusion criteria included nuclear opalescence cataract
Corresponding author: Kerry D. Solomon, MD, 1101 Clarity Road, LOCS II grading of NIV,11 planned multiple procedures at
Suite 100, Mount Pleasant, South Carolina 29464, USA. E-mail: the time of surgery, previous intraocular or corneal surgery
[email protected]. (eg, refractive or therapeutic), a poorly dilating pupil or
Outcome Measures
The primary efficiency outcomes were CDE and aspira-
tion fluid used. The secondary efficiency outcome was aspi-
ration time. Estimated fluid use, which was calculated by
each phaco machine, was evaluated as a supportive effi-
ciency outcome. The CDE was calculated using the same for-
mula for the active-fluidics system and the gravity-fluidics
system (CDE Z average energy amplitude duty
cycle time in foot position 3 [ie, active US time]). The aspi-
ration fluid was a balanced salt solution and was measured
by weighing the drainage bag to the nearest tenth of a gram
(ie, weight of fluid used Z weight before surgery weight
after surgery; 1 mL balanced salt solution Z 1 g balanced
salt solution). The CDE, aspiration time, and estimated aspi-
ration fluid used were recorded from the display on each
phaco system's user interface. Safety outcomes included
adverse events and device deficiencies that might have
occurred during the 3-month follow-up period.
Statistical Analysis
A sample size of 90 patients with complete data for both
eyes per surgical configuration was determined to be suffi-
cient to detect a between-configuration CDE difference of
more than 15% with 80% power at a 2-sided a of 0.05,
assuming a standard deviation (SD) of 50% of the mean
and a treatment effect of 0.3. A sample size of 90 patients
per configuration was also determined to be sufficient to
detect a difference in aspiration fluid used of at least 15%
Figure 1. Active-fluidics (A) and gravity-fluidics (B) surgical config- with 80% power at a 2-sided a of 0.05.
urations. Phacoemulsifier/aspirator systems, US tips, and infusion All patients who were randomized to a surgical configura-
sleeves are shown (ABS Z aspiration bypass system). tion for first-eye surgery comprised the intent-to-treat data-
set. All patients who received surgery were included in the
safety-analysis dataset. Data were summarized descriptively
pupil defect that prevented dilation to 5.0 mm or more or a for patient demographics and preoperative characteristics,
need for mechanical or surgical manipulation to enlarge efficiency outcomes, and safety outcomes. A random-effect
the pupil at the time of surgery, current or previous use of analysis of covariance model was used to test the treatment
an a1-selective or an a1A-selective adrenoceptor antagonist, differences in the primary and secondary efficiency out-
diagnosis of severe retinal disorders or history of retinal comes between the active-fluidics configuration and
detachment, clinically significant corneal endothelial dystro- gravity-fluidics configuration; this analysis was based on
phy, history of corneal disease, IOP greater than 21 mm Hg, the intent-to-treat dataset. Investigator site was included as
weak or broken zonular fibers, known zonular instability, or a covariate in the model. Analysis of the primary outcomes
zonular dehiscence. used a fixed sequence procedure, wherein statistical compar-
ison of aspiration fluid used was performed only if the com-
parison of CDE returned a statistically significant difference
Surgical Technique between configurations. Analysis of the supportive outcome,
Surgery was performed according to site-specific stan- aspiration time, was performed only if both primary out-
dard operating procedures: combination of divide-and- comes were significant. Two-sided P values less than 0.05
conquer plus stop-and-chop (K.D.S.), vertical chop (R.L.), were considered statistically significant.
and 4-quadrant divide-and-conquer (R.J.C.). Clear corneal
incisions of 2.2 to 2.4 mm and manually created capsulo- RESULTS
rhexes of 5.0 to 5.5 mm were used for all surgeries. Use of
the same ophthalmic viscosurgical device(s) (OVD) for a pa- Patients
tient's left eye and right eye was required: Duovisc (sodium One hundred patients were randomized to the first-
hyaluronate 3%chondroitin sulfate 4.0% with sodium eye surgery configuration (n Z 100 eyes per configura-
hyaluronate 1.0%) OVD system (K.D.S., R.J.C.) and Viscoat
(sodium hyaluronate 3.0%chondroitin sulfate 4.0%)Pro- tion; first-eye and second-eye surgeries combined) and
visc (sodium hyaluronate 1.0%) combination (R.L.). were included in the intent-to-treat dataset. Of these,
Phacoemulsification was performed using the surgical 98 patients had surgery and were included in the
DISCUSSION
Cataract surgery, in particular small-incision phaco-
emulsification/aspiration cataract extraction, is gener-
Figure 3. Aspiration fluid used. A: Fluid used measured by weight ally a safe procedure.12 Advances in technology and
(least squares mean G standard error). The least squares estimate surgical techniques have shortened surgical times,
of the difference between group means is shown above bars. The reduced the risk, and improved outcomes.10,1316 Like-
P value was determined using an analysis of covariance model. B: wise, phaco systems that facilitate improved surgical
Fluid used as estimated by each phacoemulsifier/aspirator system
efficiency with reduced active instrumentation times,
compared with fluid used as measured by weight (mean G SD).
energy dissipated at the incision site, and fluid circula-
tion through the anterior chamber might further
No serious ocular adverse events or device defi- reduce the risk for potential surgical complications.
ciencies occurred. Two serious adverse events were re- In this contralateral-eye study, the CDE, aspiration
ported (1 fatal myocardial infarction and 1 infective fluid used, and aspiration time were significantly lower
exacerbation of chronic obstructive airway disease); for phacoemulsification cataract surgery with the
Patients, n (%)
Active-Fluidics Gravity-Fluidics
Configuration Configuration
Event (n Z 98 Eyes) (n Z 98 Eyes)*
experience with the Centurion Vision System, the lack 2. Uy HS, Edwards K, Curtis N. Femtosecond phacoemulsification:
of longer experience and ideal predetermined settings the business and the medicine. Curr Opin Ophthalmol 2012;
23:3339
was a challenge. Assessing the surgical efficiency of 3. Meyer JJ, Kuo AF, Olson RJ. The risk of capsular breakage from
the of the new system with more experienced surgeons phacoemulsification needle contact with the lens capsule: a
and more complex cases, such as cases of brunescent laboratory study. Am J Ophthalmol 2010; 149:882886
cataracts, might provide additional important data 4. Tsinopoulos IT, Lamprogiannis LP, Tsaousis KT, Mataftsi A,
regarding the surgical efficiency of this system. Future Symeonidis C, Chalvatzis NT, Dimitrakos SA. Surgical out-
comes in phacoemulsification after application of a risk stratifica-
studies focusing on outcome metrics, such as postop- tion system. Clin Ophthalmol 2013; 7:895899. Available at:
erative changes in central corneal thickness and endo- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663436/pdf/opth-
thelial cell density, are needed to provide an 7-895.pdf. Accessed February 2, 2016
understanding of the clinical relevance of improved 5. Sharif-Kashani P, Fanney D, Injev V. Comparison of occlusion
surgical efficiency during cataract procedures. break responses and vacuum rise times of phacoemulsification
systems. BMC Ophthalmol 2014; 14:96. Available at: http://
In conclusion, the CDE, aspiration fluid used, and www.biomedcentral.com/content/pdf/1471-2415-14-96.pdf. Ac-
aspiration time were significantly lower during phaco- cessed February 2, 2016
emulsification cataract extraction surgery with the 6. Sorensen T, Chan CC, Bradley M, Braga-Mele R, Olson RJ. A
active-fluidics configuration than with the gravity- comparison of cataract surgical practices in Canada and the
fluidics configuration. The results in this clinical study United States. Can J Ophthalmol 2012; 47:131139
7. Han YK, Miller KM. Heat production: longitudinal versus
show that the active-fluidics configuration offers torsional phacoemulsification. J Cataract Refract Surg 2009;
improved surgical efficiency, with less energy deliv- 35:17991805
ered to the incision site, less fluid passing through 8. Jun B, Berdahl JP, Kim T. Thermal study of longitudinal and
the anterior chamber into the aspiration line, and less torsional ultrasound phacoemulsification; tracking the tempera-
active surgical instrumentation time as measured by ture of the corneal surface, incision, and handpiece. J Cataract
Refract Surg 2010; 36:832837
CDE, aspiration fluid used, and aspiration time, 9. Vasavada AR, Raj SM, Patel U, Vasavada V, Vasavada V. Com-
respectively. No serious ocular adverse events or parison of torsional and microburst longitudinal phacoemulsifi-
device deficiencies occurred, suggesting that cataract cation: a prospective, randomized, masked clinical trial.
extraction surgery with the active-fluidics configura- Ophthalmic Surg Lasers Imaging 2010; 41:109114
tion is safe as well as efficient. 10. Christakis PG, Braga-Mele RM. Intraoperative performance and
postoperative outcome comparison of longitudinal, torsional,
and transversal phacoemulsification machines. J Cataract
Refract Surg 2012; 38:234241
WHAT WAS KNOWN 11. Chylack LT Jr, Leske MC, McCarthy D, Khu P, Kashiwagi T,
Phacoemulsification cataract surgery is considered a safe Sperduto R. Lens Opacities Classification System II (LOCS II).
procedure; however, technological advances continue to Arch Ophthalmol 1989; 107:991997
12. American Academy of Ophthalmology. Cataract in the Adult
improve patient outcomes.
Eye; Preferred Practice Pattern. San Francisco, CA, American
Academy of Ophthalmology, 2011; Available at: http://www.aao.
org/asset.axd?idZ8d66318f-ff50-408e-9bb1-73d277cf14ce. Ac-
WHAT THIS PAPER ADDS cessed February 2, 2016
Surgery performed with the active-fluidics configuration J, Rodrguez-Prats JL, Galal A, Ramzy M. Outcomes of mi-
13. Alio
croincision cataract surgery versus coaxial phacoemulsification.
had less CDE, less aspiration fluid used, and less aspira-
Ophthalmology 2005; 112:19972003
tion time than the gravity-fluidics configuration, indicating 14. Park J, Yum HR, Kim MS, Harrison AR, Kim EC. Comparison of
that surgical efficiency is improved with the active-fluidics phaco-chop, divide-and-conquer, and stop-and-chop phaco
configuration. techniques in microincision coaxial cataract surgery.
J Cataract Refract Surg 2013; 39:14631469
Better surgical efficiency has been associated with less 15. Stein JD. Serious adverse events after cataract surgery. Curr
ocular trauma and better postsurgical recovery. The Opin Ophthalmol 2012; 23:219225
active-fluidics configuration was more efficient than the 16. DelMonte DW, Kim T. Anatomy and physiology of the cornea.
J Cataract Refract Surg 2011; 37:588598
gravity-fluidics configuration system.
17. Thirumalai B, Baranyovits PR. Intraocular pressure changes
and the implications on patient review after phacoemulsification.
J Cataract Refract Surg 2003; 29:504507
18. Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and
analysis of the pathogenic factors in patients after cataract sur-
REFERENCES gery. Cornea 2007; 26(suppl 1):S16S20
1. Lundstrom M, Barry P, Henry Y, Rosen P, Stenevi U. Evidence- 19. Hilford D, Hilford M, Mathew A, Polkinghorne PJ. Posterior
based guidelines for cataract surgery: guidelines based on data vitreous detachment following cataract surgery. Eye (Lond)
in the European Registry of Quality Outcomes for Cataract and 2009; 23:13881392. Available at: http://www.nature.com/eye/
Refractive Surgery database. J Cataract Refract Surg 2012; journal/v23/n6/pdf/eye2008273a.pdf. Accessed February 2,
38:10861093 2016
OTHER CITED MATERIALS presented at the ASCRS Symposium on Cataract, IOL and
A. Nicoli B, Dimalanta R, Miller KM, Medicion de Estabilidad de Refractive Surgery, Boston, Massachusetts, USA, April
Presio n Intraocular y Comparacio n entre Sistemas de 2014. Abstract available at: https://ascrs.confex.com/ascrs/
Facoemulsificacio n Controladas Activamente y por Gravedad 14am/webprogram/Paper5279.html. Accessed February 2,
[Intraocular Pressure Stability Measurement and Comparison 2016
Between Gravity-Fed and Actively-Controlled Phacoemulsifica- C. U.S. National Institutes of Health Clinical Trials. Intra-
tion Systems], presented at the VII Congreso ALACCSA-R del Operative Metrics With CENTURION and INFINITY
Hemisferio Sur, Buenos Aires, Argentina, October 2014 Vision Systems. NCT01848288. Available at: https://clinical
B. Boukhny M, Sorensen GP, Gordon R, Novel Phacoemulsifi- trials.gov/ct2/show/NCT01848288. Accessed February 2,
cation System Using Feedback-Based IOP Target Control, 2016
www.xuebalib.com
24 IP